TickerFacts.

AN2 Therapeutics, Inc. (ANTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

30.22M
Year ended 2025-12-31
2021-12-31: 2.64M2022-12-31: 15.34M2023-12-31: 23.60M2024-12-31: 29.83M2025-12-31: 30.22M30.22M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3130.22M+1.3%2026-03-17, From 2025-01-01
2024-12-3129.83M+26.4%2026-03-17, From 2024-01-01
2023-12-3123.60Mn/c2025-03-25, From 2023-01-01
2022-12-3115.34M+481.5%2024-03-29, From 2022-01-01
2021-12-312.64Mn/a2023-03-29, From 2021-01-01